Anti-inflammatory Compound Shows Therapeutic Safety and Efficacy against Flavivirus Infection
Author(s) -
Fu-Kai Chuang,
ShihMing Huang,
ChingLen Liao,
AnRong Lee,
ShuPei Lien,
YuLung Chiu,
Tsung-Hsien Chang,
Pei-Ling Tsai,
Ren-Jye Lin,
ChihChin Shih,
YiJing Tsai,
GuJiun Lin,
Li-Chen Yen
Publication year - 2019
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.00941-19
Subject(s) - zika virus , dengue virus , flavivirus , virology , dengue fever , japanese encephalitis , virus , outbreak , encephalitis , flaviviridae , medicine , biology , immunology , viral disease
Flaviviruses comprise several medically important viruses, including Japanese encephalitis virus, West Nile virus, dengue virus (DENV), yellow fever virus, and Zika virus (ZIKV). A large outbreak of DENV and ZIKV occurred recently, leading to many cases of illness and death. However, despite decades of effort, we have no clinically specific therapeutic drugs against DENV and ZIKV. Previous studies showed that inflammatory responses play a critical role in dengue and Zika virus pathogenesis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom